Large-scale Testing of BRCA Mutations Can Be Cost-Effective, Study Finds

Home / Blog / Large-scale Testing of BRCA Mutations Can Be Cost-Effective, Study Finds
Large-scale Testing of BRCA Mutations Can Be Cost-Effective, Study Finds
August 19, 2020August 19, 2020
0

Screening the overall population for mutations in the genes BRCA1 and BRCA2 that can cause breast and ovarian cancer is cost-effective in wealthier countries, from the viewpoint of both payers and society, an economic analysis study suggests. But these screenings are still too expensive to be cost-effective in less wealthy countries under such an analysis. “We must invest in cancer prevention — this is what will save most lives and also be cost effective within cash-strapped healthcare systems,”…

You must be logged in to read/download the full post.

The post Large-scale Testing of BRCA Mutations Can Be Cost-Effective, Study Finds appeared first on BioNewsFeeds.